Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan

被引:103
作者
Elgundi, Zehra [1 ]
Papanicolaou, Michael [2 ,3 ,4 ]
Major, Gretel [2 ,3 ]
Cox, Thomas R. [2 ,3 ,5 ]
Melrose, James [1 ,6 ]
Whitelock, John M. [1 ]
Farrugia, Brooke L. [1 ,7 ]
机构
[1] UNSW Sydney, Grad Sch Biomed Engn, Sydney, NSW, Australia
[2] UNSW Sydney, Garvan Inst Med Res, Darlinghurst, NSW, Australia
[3] UNSW Sydney, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia
[4] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia
[5] UNSW Sydney, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia
[6] Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, Raymond Purves Bone & Joint Res Labs, St Leonards, NSW, Australia
[7] Univ Melbourne, Melbourne Sch Engn, Dept Biomed Engn, Melbourne, Vic, Australia
来源
FRONTIERS IN ONCOLOGY | 2020年 / 9卷
基金
澳大利亚国家健康与医学研究理事会;
关键词
cancer metastasis; heparan sulfate proteoglycan; perlecan; heparanase; therapeutic; FIBROBLAST-GROWTH-FACTOR; BASEMENT-MEMBRANE PROTEOGLYCANS; SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; HUMAN BREAST; TUMOR-GROWTH; ENDOTHELIAL-CELLS; FACTOR-RECEPTOR; IN-VITRO; HEPATOCELLULAR-CARCINOMA;
D O I
10.3389/fonc.2019.01482
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer metastasis is the dissemination of tumor cells to new sites, resulting in the formation of secondary tumors. This process is complex and is spatially and temporally regulated by intrinsic and extrinsic factors. One important extrinsic factor is the extracellular matrix, the non-cellular component of tissues. Heparan sulfate proteoglycans (HSPGs) are constituents of the extracellular matrix, and through their heparan sulfate chains and protein core, modulate multiple events that occur during the metastatic cascade. This review will provide an overview of the role of the extracellular matrix in the events that occur during cancer metastasis, primarily focusing on perlecan. Perlecan, a basement membrane HSPG is a key component of the vascular extracellular matrix and is commonly associated with events that occur during the metastatic cascade. Its contradictory role in these events will be discussed and we will highlight the recent advances in cancer therapies that target HSPGs and their modifying enzymes.
引用
收藏
页数:18
相关论文
共 266 条
  • [1] Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA
    Adatia, R
    Albini, A
    Carlone, S
    Giunciuglio, D
    Benelli, R
    Santi, L
    Noonan, DM
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (12) : 1257 - 1261
  • [2] Glycosaminoglycans: key players in cancer cell biology and treatment
    Afratis, Nikos
    Gialeli, Chrisostomi
    Nikitovic, Dragana
    Tsegenidis, Theodore
    Karousou, Evgenia
    Theocharis, Achilleas D.
    Pavao, Mauro S.
    Tzanakakis, George N.
    Karamanos, Nikos K.
    [J]. FEBS JOURNAL, 2012, 279 (07) : 1177 - 1197
  • [3] Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
    Aikawa, Takurna
    Whipple, Chery A.
    Lopez, Martha E.
    Gunn, Jason
    Young, Alison
    Lander, Arthur D.
    Korc, Murray
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) : 89 - 99
  • [4] Non-Anticoagulant Heparin Prodrug Loaded Biodegradable and Injectable Thermoresponsive Hydrogels for Enhanced Anti-Metastasis Therapy
    Andrgie, Abegaz Tizazu
    Mekuria, Shewaye Lakew
    Addisu, Kefyalew Dagnew
    Hailemeskel, Balkew Zewge
    Hsu, Wei-Hsin
    Tsai, Hsieh-Chih
    Lai, Juin-Yih
    [J]. MACROMOLECULAR BIOSCIENCE, 2019, 19 (05)
  • [5] SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy
    Anh Thu Bui
    Laurent, Fanny
    Havard, Maryline
    Dautry, Francois
    Tchenio, Thierry
    [J]. CELL CYCLE, 2015, 14 (08) : 1218 - 1231
  • [6] [Anonymous], BMC MED
  • [7] [Anonymous], J PHARM RES, DOI DOI 10.1016/j.jopr.2013.08.024
  • [8] Heparanase and cancer progression: New directions, new promises
    Arvatz, Gil
    Weissmann, Marina
    Ilan, Neta
    Vlodavsky, Israel
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2253 - 2256
  • [9] PERLECAN, BASAL LAMINA PROTEOGLYCAN, PROMOTES BASIC FIBROBLAST GROWTH FACTOR-RECEPTOR BINDING, MITOGENESIS, AND ANGIOGENESIS
    AVIEZER, D
    HECHT, D
    SAFRAN, M
    EISINGER, M
    DAVID, G
    YAYON, A
    [J]. CELL, 1994, 79 (06) : 1005 - 1013
  • [10] The rationale for targeting the LOX family in cancer
    Barker, Holly E.
    Cox, Thomas R.
    Erler, Janine T.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (08) : 540 - 552